Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
2013 · The Lancet · 352 citations
https://doi.org/10.1016/s0140-6736(13)60023-9
H
Hans Perrild
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
239
Papers
11.4K
Citations
60
h-index
144
i10-index
Hans Perrild is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Thyroid Disorders and Treatments & Thyroid Cancer Diagnosis and Treatment & Diabetes and associated disorders. The author has an h-index of 60, co-authored 204 publications.
Papers by this author
worksLifestyle intervention for type 2 diabetes patients – trial protocol of The Copenhagen Type 2 Diabetes Rehabilitation Project
2009 · BMC Public Health · 43 citations
https://doi.org/10.1186/1471-2458-9-166
A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): study rationale and design
2012 · BMC Endocrine Disorders · 18 citations
https://doi.org/10.1186/1472-6823-12-10
Effects of 18-months metformin versus placebo in combination with three insulin regimens on RNA and DNA oxidation in individuals with type 2 diabetes: A post-hoc analysis of a randomized clinical trial
2021 · Free Radical Biology and Medicine · 2 citations
https://doi.org/10.1016/j.freeradbiomed.2021.11.028
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat